MRI Characterization of Mammographically Detected DCIS
MRI Characterization of Mammographically Detected Calcifications and Ductal Carcinoma in Situ
Sponsor: National Cancer Institute (NCI)
Listed as NCT03495011, this observational or N/A phase trial focuses on Breast Cancer, Stage 0 and remains ongoing. Sponsored by National Cancer Institute (NCI), it has been updated 19 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
19 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Aug 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Feb 2025 — Aug 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 14 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Jun 2023 — Jan 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Mar 2023 — Jun 2023 [monthly]
Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Recruiting
-
Feb 2022 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Feb 2022 [monthly]
Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Jul 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Jun 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .